V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 310005391 | 310007031 | 1.56 | 70.9 | Curative (C) | 2017-08-30 | 2017-09-10 | Cisplatin + Vinorelbine (PO) | N | N | 310014792 | TEMOZOLOMIDE |
| 310005392 | 310002489 | 1.47 | null | Disease modification (D) | 2014-09-02 | 2014-09-27 | CVP R + GEMCITABINE | N | N | 310014856 | FEC + DOCETAXEL |
| 310005393 | 310002490 | null | 0 | Palliative (P) | 2018-04-23 | 2018-04-23 | DABRAFENIB | N | N | 310014920 | CETUXIMAB + RT |
| 310005394 | 310002490 | 1.67 | 53.5 | Palliative (P) | 2017-06-26 | 2017-06-27 | CVP R | N | N | 310014920 | DOCETAXEL |
| 310005395 | 310002491 | null | 67.2 | null | 2015-07-31 | 2015-07-31 | Bevacizumab + Oxaliplatin +MdG | N | null | 310015048 | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL |
| 310005396 | 310002492 | 1.84 | 107.5 | Palliative (P) | 2014-10-08 | 2015-02-02 | Carboplatin+Fluorouracil 4 or 5 day | 02 | N | 310015053 | CYTARABINE HD + METHOTREXATE HD |
| 310005397 | 310002493 | 1.64 | 0 | Curative (C) | 2018-05-03 | 2018-05-05 | Bevacizumab 7.5mg/kg | N | N | 310015366 | DHAP |
| 310005398 | 310002494 | 1.62 | 98.3 | Palliative (P) | 2014-02-26 | 2014-02-27 | Capecitabine + Mitomycin | 02 | null | 310015515 | CARBO + FLUOROURACIL |
| 310005399 | 310002495 | null | null | Palliative (P) | null | 2019-03-04 | DOCETAXEL + GEMCITABINE | N | null | 310015516 | ETOPOSIDE + IFOSFAMIDE |
| 310005400 | 310002496 | 1.82 | 87 | Palliative (P) | 2016-12-28 | 2017-01-01 | Azacitidine | 2 | N | 310015715 | HCX |
| 310005401 | 310002497 | null | 80 | Adjuvant (A) | 2017-01-14 | 2017-01-23 | Enzalutamide | N | N | 310015735 | CETUXIMAB |
| 310005402 | 310002498 | 1.63 | 66 | Not known (9) | 2016-02-02 | 2016-02-02 | Capecitabine + Cisplatin + RT | 99 | N | 310015779 | FEC + DOCETAXEL |
| 310005403 | 310002499 | 1.8 | 71.9 | null | 2014-11-28 | 2014-12-03 | POUT TRIAL | 2 | N | 310015980 | DABRAFENIB + TRAMETINIB |
| 310005404 | 310002499 | 1.84 | 65.4 | Disease modification (D) | 2018-02-28 | 2018-02-28 | ALL UKALL2011 Ind B Sht Dex (PAsp) | N | N | 310015980 | CYCLOPHOSPHAMIDE + ETOPOSIDE |
| 310005405 | 310002500 | 1.74 | 83.3 | Adjuvant (A) | 2016-11-29 | 2016-12-01 | BLEOMYCIN + CARBOPLATIN + ETOPOSIDE | N | null | 310016151 | BRENTUXIMAB |
| 310005406 | 310002501 | 1.79 | 114.2 | Palliative (P) | 2014-05-31 | 2014-06-19 | Carboplatin+Fluorouracil 4 or 5 day | 02 | N | 310016194 | DOCETAXEL |
| 310005407 | 310002502 | null | 72 | null | 2016-04-26 | 2016-05-03 | Alemtuzumab | N | null | 310016272 | ALEMTUZUMAB |
| 310005408 | 310002503 | null | 62.4 | Disease modification (D) | 2018-04-23 | 2018-06-18 | Cisplatin + Fluorouracil + RT 5day | N | null | 310016337 | CHLVPP |
| 310005409 | 310002504 | 1.54 | null | Palliative (P) | 2016-12-20 | 2016-12-28 | CAPECITABINE + EPIRUBICIN + OXALIPLATIN | N | N | 310016402 | MITOXANTRONE |
| 310005410 | 310002505 | 1.68 | 55.5 | Palliative (P) | 2017-08-05 | 2017-08-09 | Bevacizumab 7.5mg/kg | 2 | null | 310016444 | CISPLATIN + DACARBAZINE |
| 310005411 | 310002505 | 1.79 | null | null | 2015-01-25 | 2015-01-26 | Abiraterone | 02 | N | 310016444 | OCTREOTIDE |
| 310005412 | 310002506 | 1.6 | 0 | Palliative (P) | 2015-07-02 | 2015-07-13 | Carboplatin+Fluorouracil 4 or 5 day | 02 | N | 310016520 | CYCLOPHOSPHAMIDE + GEMCITABINE + VINCRISTINE |
| 310005413 | 310002507 | 1.5 | 66.6 | Palliative (P) | 2017-01-07 | 2017-01-08 | CAPECITABINE + TEMOZOLOMIDE | 02 | N | 310016521 | CARBO + FLUOROURACIL |
| 310005414 | 310002508 | 1.75 | 69.8 | Palliative (P) | 2014-03-13 | 2014-03-24 | CARBOPLATIN + VINORELBINE | 01 | N | 310016775 | SUNITINIB |
| 310005415 | 310002509 | 0 | 76.4 | Palliative (P) | 2014-02-25 | 2014-03-01 | CYCLOPHOSPHAMIDE + GEMCITABINE + VINCRISTINE | null | N | 310016807 | FCR |
| 310005416 | 310002510 | 1.65 | 45.8 | Curative (C) | 2013-03-30 | 2013-04-09 | Temozolomide 200mg/m2 | N | N | 310016872 | CYCLO + ETOPOSIDE + VINCRISTINE |
| 310005417 | 310002511 | null | 107 | Disease modification (D) | 2015-06-10 | 2015-07-03 | ECarboX | N | Y | 310016998 | ECARBOX |
| 310005418 | 310002511 | null | 80 | Curative (C) | 2016-03-03 | 2016-03-11 | ALL UKALL60+ TRIAL | 2 | N | 310016998 | OCTREOTIDE |
| 310005419 | 310002512 | 1.66 | 54 | Not known (9) | 2018-08-07 | 2018-08-07 | Bevacizumab 15mg/kg | N | N | 310017116 | CARBOPLATIN + PACLITAXEL + RT |
| 310005420 | 310002512 | 1.61 | 66.6 | Curative (C) | 2016-04-06 | 2016-04-07 | VAC | N | N | 310017116 | FEC + DOCETAXEL |
| 310005421 | 310002513 | 1.69 | 78 | Palliative (P) | 2016-09-04 | 2016-09-07 | Bevacizumab+Carbo+Gemcitabine | N | N | 310017336 | CYCLO + ETOPOSIDE + VINCRISTINE |
| 310005422 | 310002514 | 1.54 | 110.4 | Palliative (P) | 2015-11-29 | 2016-01-03 | Methotrexate 10mg/m2 po 7day | N | N | 310017346 | BRENTUXIMAB |
| 310005423 | 310002514 | null | 86 | null | 2018-02-15 | 2018-02-19 | ALL UKALL2011 Ind B Sht Dex (PAsp) | Y | Y | 310017346 | METHOTREXATE |
| 310005424 | 310002515 | 1.63 | 72.5 | Disease modification (D) | 2016-01-27 | 2016-03-06 | Methotrexate High Dose (3g/m2) | null | N | 310017481 | DOXORUBICIN + IFOSFAMIDE |
| 310005425 | 310002516 | 1.69 | 0 | Palliative (P) | 2016-03-18 | 2016-04-04 | Carboplatin + Liposomal Doxorubicin | 02 | Y | 310017980 | CETUXIMAB |
| 310005426 | 310002516 | null | null | Palliative (P) | 2015-10-10 | 2015-10-10 | Bevacizumab 7.5mg/kg | 02 | null | 310017980 | FEC |
| 310005427 | 310002516 | 1.8 | 68.6 | Curative (C) | 2018-12-03 | 2018-12-03 | R GCVP | 02 | null | 310017980 | CETUXIMAB + CISPLATIN + FLUOROURACIL |
| 310005428 | 310002517 | 1.68 | 92.2 | Palliative (P) | 2018-12-27 | 2019-01-03 | CARBOPLATIN + RT | N | N | 310018382 | DOCETAXEL |
| 310005429 | 310007039 | null | 94.6 | null | 2017-10-02 | 2017-10-14 | CHLVPP | N | null | 310018395 | CAPECITABINE + EPIRUBICIN + OXALIPLATIN |
| 310005430 | 310002518 | null | 80 | Palliative (P) | 2016-05-20 | 2016-06-04 | CYCLOPHOSPHAMIDE | N | N | 310018438 | CARBO + FLUOROURACIL |
| 310005431 | 310002519 | 1.7 | 0 | null | 2018-04-04 | 2018-04-04 | ICON8B TRIAL | N | N | 310018510 | INCA TRIAL |
| 310005432 | 310002519 | null | null | Palliative (P) | 2014-09-22 | 2014-09-24 | BLEOMYCIN | N | N | 310018510 | METHOTREXATE |
| 310005433 | 310002520 | 1.83 | 67.1 | Curative (C) | 2017-02-10 | 2017-02-10 | OCTREOTIDE | N | N | 310018549 | BENDAMUSTINE + RITUXIMAB |
| 310005434 | 310002521 | 1.66 | 66.4 | Palliative (P) | 2016-05-04 | 2016-05-11 | CRIZOTINIB | Y | N | 310018611 | CAPECITABINE + EPIRUBICIN + OXALIPLATIN |
| 310005435 | 310002522 | 1.85 | 99.2 | Disease modification (D) | 2016-03-28 | 2016-03-29 | Alemtuz+Fludara+Melphalan RIC MUD | N | N | 310018815 | CYTARABINE + METHOTREXATE + RITUXIMAB + THIOTEPA |
| 310005436 | 310007041 | 1.57 | null | Curative (C) | 2014-03-12 | 2014-03-22 | METHOTREXATE | N | null | 310018837 | CISPLATIN + DOCETAXEL |
| 310005437 | 310009277 | 1.83 | null | Palliative (P) | 2017-10-23 | 2017-10-24 | Cisplatin + Fluorouracil + RT 5day | 2 | N | 310018860 | CVP R |
| 310005438 | 310002523 | 1.52 | 56.9 | Palliative (P) | 2015-08-17 | 2015-08-17 | Sunitinib | N | Y | 310018979 | NEOSCOPE TRIAL |
| 310005439 | 310007042 | 1.64 | null | Not known (9) | 2014-04-01 | 2014-04-25 | STS Rhabdomyosarcoma RMS 2005 IVADo | N | Y | 310019072 | CISPLATIN + PEMETREXED |
| 310005441 | 310007043 | 1.57 | null | Curative (C) | 2018-02-07 | 2018-02-07 | Temozolomide + RT | N | N | 310019434 | EC |